✦ LIBER ✦

The use of the selective serotonin S2 receptor antagonist Ketanserin in the treatment of Raynaud's phenomenon

✍ Scribed by Dormandy, John A.; Berent, Anna; Downes, Susan J.M.

Book ID: 123330766
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 400 KB
Volume: 2
Category: Article
ISSN: 0950-821X
DOI: 10.1016/S0950-821X(88)80014-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of raynaud's phenomenon with k

Treatment of raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor

✍ James R. Seibold; Anton H. M. Jageneau 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 787 KB

Ketanserin in the treatment of Raynaud's

Ketanserin in the treatment of Raynaud's phenomenon associated with generalized scleroderma

✍ M. ENGELHART 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Effect of chronic ketanserin treatment o

Effect of chronic ketanserin treatment on serotonin-induced platelet aggregation in patients with Raynaud's phenomenon

✍ B. Marasini; M. L. Biondi; R. Mollica 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 221 KB

The treatment of Raynaud's phenomenon

✍ PAULINE M. DOWD 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

The treatment of Raynaud's phenomenon

✍ Seibold, James R.; Allegar, Nancy E. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 529 KB

Nicardipine in the treatment of raynaud'

Nicardipine in the treatment of raynaud's phenomenon

✍ Fredrick M. Wigley; Robert A. Wise; Raymond Malamet; Thomas E. Scott 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

A new calcium channel blocker, nicardipine, was studied for treatment of Raynaud's phenomenon in a double-blind, placebo-controlled, crossover trial during the winter months. Clinical response was assessed by a patient-kept diary of symptoms and finger systolic pressure that was measured at room tem